Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study

Martin J Elliott, Paolo De Coppi, Simone Speggiorin, Derek Roebuck, Colin R Butler, Edward Samuel, Claire Crowley, Clare McLaren, Anja Fierens, David Vondrys, Lesley Cochrane, Christopher Jephson, Samuel Janes, Nicholas J Beaumont, Tristan Cogan, Augustinus Bader, Alexander M Seifalian, J Justin Hsuan, Mark W Lowdell, Martin A Birchall

Research output: Contribution to journalArticle (Academic Journal)

295 Citations (Scopus)

Abstract

BACKGROUND: Stem-cell-based, tissue engineered transplants might offer new therapeutic options for patients, including children, with failing organs. The reported replacement of an adult airway using stem cells on a biological scaffold with good results at 6 months supports this view. We describe the case of a child who received a stem-cell-based tracheal replacement and report findings after 2 years of follow-up. METHODS: A 12-year-old boy was born with long-segment congenital tracheal stenosis and pulmonary sling. His airway had been maintained by metal stents, but, after failure, a cadaveric donor tracheal scaffold was decellularised. After a short course of granulocyte colony stimulating factor, bone marrow mesenchymal stem cells were retrieved preoperatively and seeded onto the scaffold, with patches of autologous epithelium. Topical human recombinant erythropoietin was applied to encourage angiogenesis, and transforming growth factor β to support chondrogenesis. Intravenous human recombinant erythropoietin was continued postoperatively. Outcomes were survival, morbidity, endoscopic appearance, cytology and proteomics of brushings, and peripheral blood counts. FINDINGS: The graft revascularised within 1 week after surgery. A strong neutrophil response was noted locally for the first 8 weeks after surgery, which generated luminal DNA neutrophil extracellular traps. Cytological evidence of restoration of the epithelium was not evident until 1 year. The graft did not have biomechanical strength focally until 18 months, but the patient has not needed any medical intervention since then. 18 months after surgery, he had a normal chest CT scan and ventilation-perfusion scan and had grown 11 cm in height since the operation. At 2 years follow-up, he had a functional airway and had returned to school. INTERPRETATION: Follow-up of the first paediatric, stem-cell-based, tissue-engineered transplant shows potential for this technology but also highlights the need for further research. FUNDING: Great Ormond Street Hospital NHS Trust, The Royal Free Hampstead NHS Trust, University College Hospital NHS Foundation Trust, and Region of Tuscany.
Original languageEnglish
JournalLancet
DOIs
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study'. Together they form a unique fingerprint.

  • Cite this

    Elliott, M. J., De Coppi, P., Speggiorin, S., Roebuck, D., Butler, C. R., Samuel, E., Crowley, C., McLaren, C., Fierens, A., Vondrys, D., Cochrane, L., Jephson, C., Janes, S., Beaumont, N. J., Cogan, T., Bader, A., Seifalian, A. M., Hsuan, J. J., Lowdell, M. W., & Birchall, M. A. (2012). Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. https://doi.org/10.1016/S0140-6736(12)60737-5